| Dr Harpreet Singh Dhatt, MD | |
|
4201 W Medical Center Dr, Mchenry, IL 60050-8409 | |
| (815) 334-5566 | |
| (815) 759-4008 |
| Full Name | Dr Harpreet Singh Dhatt |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 15 Years |
| Location | 4201 W Medical Center Dr, Mchenry, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306164041 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | A130649 (California) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 036157584 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy San Juan Medical Center | Carmichael, CA | Hospital |
| Mercy General Hospital | Sacramento, CA | Hospital |
| Woodland Memorial Hospital | Woodland, CA | Hospital |
| Mercy Hospital Of Folsom | Folsom, CA | Hospital |
| Methodist Hospital Of Sacramento | Sacramento, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dignity Health Medical Foundation | 7810800661 | 1209 |
News Archive
The incidence of tuberculosis (TB) in the U.S. is reported as being on the decrease, however untreated infected people act as a reservoir for disease. Any pool of the world's population harboring this disease gives cause for concern, especially since the BCG vaccine is only 70-80% effective at best. New research published in BioMed Central's open access journal BMC Public Health, shows that in 2009 the number of cases of TB reported across America was much lower than that recorded in previous years.
Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced a net loss of $4.1 million or $0.58 per diluted share on net sales from continuing operations of $73.9 million for the fiscal year ended June 30, 2009.
Chinese stem cell scientists have published new research that improves the survival and effectiveness of transplanted stem cells. The research led by Dr Hsiao Chang Chan, from the Chinese University of Hong Kong, is published in Stem Cells.
Bayer HealthCare Pharmaceuticals today announced that XARELTO (rivaroxaban), a novel anti-clotting therapy, achieved improvement in net clinical benefit in a study looking at treatment of patients with deep vein thrombosis. DVT is the formation of a blood clot in a deep vein, usually in the legs, that partially or totally blocks the flow of blood.
Researchers at the Center for Smart and Connected Society at the University of Massachusetts Amherst recently released a new digital contact-tracing technique that is based on widely-deployed Wi-Fi technology.
› Verified 2 days ago
| Entity Name | Dignity Health Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700803418 PECOS PAC ID: 7810800661 Enrollment ID: O20031107000709 |
News Archive
The incidence of tuberculosis (TB) in the U.S. is reported as being on the decrease, however untreated infected people act as a reservoir for disease. Any pool of the world's population harboring this disease gives cause for concern, especially since the BCG vaccine is only 70-80% effective at best. New research published in BioMed Central's open access journal BMC Public Health, shows that in 2009 the number of cases of TB reported across America was much lower than that recorded in previous years.
Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced a net loss of $4.1 million or $0.58 per diluted share on net sales from continuing operations of $73.9 million for the fiscal year ended June 30, 2009.
Chinese stem cell scientists have published new research that improves the survival and effectiveness of transplanted stem cells. The research led by Dr Hsiao Chang Chan, from the Chinese University of Hong Kong, is published in Stem Cells.
Bayer HealthCare Pharmaceuticals today announced that XARELTO (rivaroxaban), a novel anti-clotting therapy, achieved improvement in net clinical benefit in a study looking at treatment of patients with deep vein thrombosis. DVT is the formation of a blood clot in a deep vein, usually in the legs, that partially or totally blocks the flow of blood.
Researchers at the Center for Smart and Connected Society at the University of Massachusetts Amherst recently released a new digital contact-tracing technique that is based on widely-deployed Wi-Fi technology.
› Verified 2 days ago
| Entity Name | Garden City Radiology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336612084 PECOS PAC ID: 6406194323 Enrollment ID: O20190423002573 |
News Archive
The incidence of tuberculosis (TB) in the U.S. is reported as being on the decrease, however untreated infected people act as a reservoir for disease. Any pool of the world's population harboring this disease gives cause for concern, especially since the BCG vaccine is only 70-80% effective at best. New research published in BioMed Central's open access journal BMC Public Health, shows that in 2009 the number of cases of TB reported across America was much lower than that recorded in previous years.
Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced a net loss of $4.1 million or $0.58 per diluted share on net sales from continuing operations of $73.9 million for the fiscal year ended June 30, 2009.
Chinese stem cell scientists have published new research that improves the survival and effectiveness of transplanted stem cells. The research led by Dr Hsiao Chang Chan, from the Chinese University of Hong Kong, is published in Stem Cells.
Bayer HealthCare Pharmaceuticals today announced that XARELTO (rivaroxaban), a novel anti-clotting therapy, achieved improvement in net clinical benefit in a study looking at treatment of patients with deep vein thrombosis. DVT is the formation of a blood clot in a deep vein, usually in the legs, that partially or totally blocks the flow of blood.
Researchers at the Center for Smart and Connected Society at the University of Massachusetts Amherst recently released a new digital contact-tracing technique that is based on widely-deployed Wi-Fi technology.
› Verified 2 days ago
| Entity Name | Radiology & Nuclear Consultants Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376535815 PECOS PAC ID: 9234114497 Enrollment ID: O20221103001609 |
News Archive
The incidence of tuberculosis (TB) in the U.S. is reported as being on the decrease, however untreated infected people act as a reservoir for disease. Any pool of the world's population harboring this disease gives cause for concern, especially since the BCG vaccine is only 70-80% effective at best. New research published in BioMed Central's open access journal BMC Public Health, shows that in 2009 the number of cases of TB reported across America was much lower than that recorded in previous years.
Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced a net loss of $4.1 million or $0.58 per diluted share on net sales from continuing operations of $73.9 million for the fiscal year ended June 30, 2009.
Chinese stem cell scientists have published new research that improves the survival and effectiveness of transplanted stem cells. The research led by Dr Hsiao Chang Chan, from the Chinese University of Hong Kong, is published in Stem Cells.
Bayer HealthCare Pharmaceuticals today announced that XARELTO (rivaroxaban), a novel anti-clotting therapy, achieved improvement in net clinical benefit in a study looking at treatment of patients with deep vein thrombosis. DVT is the formation of a blood clot in a deep vein, usually in the legs, that partially or totally blocks the flow of blood.
Researchers at the Center for Smart and Connected Society at the University of Massachusetts Amherst recently released a new digital contact-tracing technique that is based on widely-deployed Wi-Fi technology.
› Verified 2 days ago
| Entity Name | Mchenry Radiologists And Imaging Associates Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083637094 PECOS PAC ID: 7810959004 Enrollment ID: O20230306000792 |
News Archive
The incidence of tuberculosis (TB) in the U.S. is reported as being on the decrease, however untreated infected people act as a reservoir for disease. Any pool of the world's population harboring this disease gives cause for concern, especially since the BCG vaccine is only 70-80% effective at best. New research published in BioMed Central's open access journal BMC Public Health, shows that in 2009 the number of cases of TB reported across America was much lower than that recorded in previous years.
Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced a net loss of $4.1 million or $0.58 per diluted share on net sales from continuing operations of $73.9 million for the fiscal year ended June 30, 2009.
Chinese stem cell scientists have published new research that improves the survival and effectiveness of transplanted stem cells. The research led by Dr Hsiao Chang Chan, from the Chinese University of Hong Kong, is published in Stem Cells.
Bayer HealthCare Pharmaceuticals today announced that XARELTO (rivaroxaban), a novel anti-clotting therapy, achieved improvement in net clinical benefit in a study looking at treatment of patients with deep vein thrombosis. DVT is the formation of a blood clot in a deep vein, usually in the legs, that partially or totally blocks the flow of blood.
Researchers at the Center for Smart and Connected Society at the University of Massachusetts Amherst recently released a new digital contact-tracing technique that is based on widely-deployed Wi-Fi technology.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Harpreet Singh Dhatt, MD 4201 W Medical Center Dr, Mchenry, IL 60050-8409 Ph: (815) 334-5566 | Dr Harpreet Singh Dhatt, MD 4201 W Medical Center Dr, Mchenry, IL 60050-8409 Ph: (815) 334-5566 |
News Archive
The incidence of tuberculosis (TB) in the U.S. is reported as being on the decrease, however untreated infected people act as a reservoir for disease. Any pool of the world's population harboring this disease gives cause for concern, especially since the BCG vaccine is only 70-80% effective at best. New research published in BioMed Central's open access journal BMC Public Health, shows that in 2009 the number of cases of TB reported across America was much lower than that recorded in previous years.
Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced a net loss of $4.1 million or $0.58 per diluted share on net sales from continuing operations of $73.9 million for the fiscal year ended June 30, 2009.
Chinese stem cell scientists have published new research that improves the survival and effectiveness of transplanted stem cells. The research led by Dr Hsiao Chang Chan, from the Chinese University of Hong Kong, is published in Stem Cells.
Bayer HealthCare Pharmaceuticals today announced that XARELTO (rivaroxaban), a novel anti-clotting therapy, achieved improvement in net clinical benefit in a study looking at treatment of patients with deep vein thrombosis. DVT is the formation of a blood clot in a deep vein, usually in the legs, that partially or totally blocks the flow of blood.
Researchers at the Center for Smart and Connected Society at the University of Massachusetts Amherst recently released a new digital contact-tracing technique that is based on widely-deployed Wi-Fi technology.
› Verified 2 days ago
Ernest A Conti, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4201 W Medical Center Dr Ste B203, Mchenry, IL 60050 Phone: 815-334-5566 Fax: 815-759-4008 | |
Abhijit Patil, Radiology Medicare: Accepting Medicare Assignments Practice Location: 4201 W Medical Center Dr, Mchenry, IL 60050 Phone: 815-334-5566 Fax: 815-759-4008 | |
Matthew Groenwald, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4201 W Medical Center Dr, Mchenry, IL 60050 Phone: 815-334-5566 Fax: 815-759-4008 | |
James T Link, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3929 Mercy Dr, Mchenry, IL 60050 Phone: 815-759-0800 Fax: 815-759-2367 | |
Milton W Hummel, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 3929 Mercy Dr, Mchenry, IL 60050 Phone: 815-759-0800 Fax: 815-759-2367 | |
Dr. Aaron Wittenberg, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4201 W Medical Center Dr, Mchenry, IL 60050 Phone: 815-334-5566 Fax: 815-759-4008 | |
Balatripura Voruganti, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4201 W Medical Center Dr, Mchenry, IL 60050 Phone: 815-334-5566 Fax: 815-759-4008 |